Advanced search×

Universal GFR determination based on two time points during plasma iohexol disappearance.

Kidney Int 80(4):423-30 (2011) PMID 21654718 PMCID PMC3146568

An optimal measurement of glomerular filtration rate (GFR) should minimize the number of blood draws, and reduce procedural invasiveness and the burden to study personnel and cost, without sacrificing accuracy. Equations have been proposed to calculate GFR from the slow compartment separately for adults and children. To develop a universal equation, we used 1347 GFR measurements from two diverse groups consisting of 527 men in the Multicenter AIDS Cohort Study and 514 children in the Chronic Kidney Disease in Children cohort. Both studies used nearly identical two-compartment (fast and slow) protocols to measure GFR. To estimate the fast component from markers of body size and of the slow component, we used standard linear regression methods with the log-transformed fast area as the dependent variable. The fast area could be accurately estimated from body surface area by a simple parameter (6.4/body surface area) with no residual dependence on the slow area or other markers of body size. Our equation measures only the slow iohexol plasma disappearance curve with as few as two time points and was normalized to 1.73 m2 body surface area. It is of the form: GFR=slowGFR/[1+0.12(slowGFR/100)]. In a random sample utilizing a third of the patients for validation, there was excellent agreement between the calculated and measured GFR with low root mean square errors being 4.6 and 1.5 ml/min per 1.73 m2 for adults and children, respectively. Thus, our proposed simple equation, developed in a combined patient group with a broad range of GFRs, may be applied universally and is independent of the injected amount of iohexol.

DOI: 10.1038/ki.2011.155
Version: za2963e q8zac q8zb9 q8zcd q8zd3 q8ze8 q8zf2 q8zg8

Similar articles you may find interesting…

  1. Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.

    Clin Infect Dis 51(8):947-56 (2010) PMID 20825306

    We assessed temporal changes in excess mortality and elucidated risk factors for excess mortality in patients with AIDS diagnosed in the era of highly active antiretroviral therapy (HAART). Methods.  We included 1188 patients of the Longitudinal Study of Ocular Complications in AIDS who were aged...
  2. Cardiovascular disease in HIV infection.

    Curr Opin HIV AIDS 6(4):266-71 (2011) PMID 21546831

    Highly active antiretroviral therapy (HAART) use has markedly reduced AIDS-related mortality and opportunistic illness. With improved survival, cardiovascular disease (CVD) has emerged as an important noninfectious chronic comorbidity among antiretroviral (ARV)-treated HIV-infected p...